Peking University i-NYS: First Implant for Congenital Nystagmus | AcademicJobs
Peking University researchers' i-NYS device gains NMPA approval as the first implantable treatment for congenital nystagmus, transforming lives through university-driven innovation.
peking-universityresearch-publication-newsbiomedical-engineering

